EBETAXEL 6MG-ML SOLU. FOR I.V. INFUSION 6 Concentrate for solution for infusion 16.7ml Vial
EBETAXEL 6MG-ML Concentrate for Solution for I.V. Infusion
Ebetaxel (Paclitaxel) is a powerful antineoplastic agent used in the treatment of various types of cancer.
This concentrate is designed for intravenous infusion, allowing for precise and effective delivery of the active ingredient.
It works by interfering with the growth of cancer cells, ultimately leading to their destruction.
For more detailed product information, refer to reputable pharmaceutical resources like Nahdi Online, , or .
Benefits of Use
Ebetaxel (Paclitaxel) is indicated for the treatment of various malignancies:
- Effective in treating advanced ovarian cancer.
- Used for breast cancer, both as adjuvant and metastatic therapy.
- Indicated for non-small cell lung cancer.
- Treatment for AIDS-related Kaposi's sarcoma.
- May be used in combination with other chemotherapeutic agents for enhanced efficacy.
How to Use
Ebetaxel 6mg/ml concentrate for solution for infusion must be administered by a qualified healthcare professional.
- The concentrate must be diluted before intravenous administration.
- Administer as a slow intravenous infusion, typically over 3 to 24 hours, as directed by a physician.
- Premedication with corticosteroids, antihistamines, and H2 antagonists is generally required to prevent hypersensitivity reactions.
- Dosage and treatment schedule are determined by the patient's condition, type of cancer, and body surface area.
- Close monitoring for adverse reactions is essential during and after infusion.
Caution & Warnings
- Ebetaxel should only be administered under the supervision of a physician experienced in chemotherapy.
- Severe hypersensitivity reactions have been reported; appropriate resuscitation equipment should be available.
- Bone marrow suppression (myelosuppression), particularly neutropenia, is a dose-limiting toxicity.
- Peripheral neuropathy is common and may be severe; dose adjustments may be necessary.
- Not recommended for use in pregnant or breastfeeding women due as it may cause fetal harm.
- Patients with severe hepatic impairment should be treated with caution, and dose reduction may be required.
- Monitor for cardiac abnormalities, including bradycardia, during infusion.
Ingredients
Each ml contains:
- Active ingredient: Paclitaxel 6 mg
- Excipients: As per pharmaceutical formulation.
Product Details
- **Form:** Concentrate for solution for infusion
- **Strength:** 6mg/ml
- **Volume:** 16.7ml vial
- **Administration Route:** Intravenous
- **Packaging:** Single-use vial
| Gtin | 35-355-06 |
|---|---|
| Recommended Sale Price | 736.15 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | PACLITAXEL |
| SFDA Reg. No | 35-355-06 |
| IBC | 35-355-06 |
| Drug Type | Prescription (Rx) |
| Scientific Name | Paclitaxel |
| Strength | 6mg/ml |
| Strength Unit | mg/ml |
| Form | Concentrate for solution for infusion |
| Admin Route | Intravenous |
| Size | 16.7ml |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 Vial |
| Storage conditions | Store below 25°C. Protect from light. Do not refrigerate or freeze. |
| Refrigerator Storage | No |

